Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dermatomyositis in children].

R Dumas1

  • 1Service de pédiatrie, CHR de Montpellier, hôpital Saint-Charles, Montpellier, France.

Pediatrie
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Juvenile dermatomyositis is a rare autoimmune disease affecting children, primarily impacting muscles and skin. Early steroid treatment offers a good prognosis, with additional therapies for non-responsive cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of markerless inconsistencies are at least as large as the effects of the marker-based soft tissue artefact.

Journal of biomechanics·2025
Same author

The Conventional Gait Model's sensitivity to lower-limb marker placement.

Scientific reports·2022
Same author

Uncertainty analysis and sensitivity of scapulothoracic joint angles to kinematic model parameters.

Medical & biological engineering & computing·2022
Same author

Subject-specific model-derived kinematics of the shoulder based on skin markers during arm abduction up to 180° - assessment of 4 gleno-humeral joint models.

Journal of biomechanics·2022
Same author

The effect of ankle and hindfoot malalignment on foot mechanics in patients suffering from post-traumatic ankle osteoarthritis.

Clinical biomechanics (Bristol, Avon)·2020
Same author

Technical considerations in lateral extra-articular reconstruction coupled with anterior cruciate ligament reconstruction: A simulation study evaluating the influence of surgical parameters on control of knee stability.

Clinical biomechanics (Bristol, Avon)·2018
Same journal

[Psychological aspects of bone marrow donation in donor brothers and sisters in bone marrow transplantation].

Pediatrie·1993
Same journal

[Lethargy in the course of treatment with ranitidine in a newborn infant].

Pediatrie·1993
Same journal

[Delayed detection of hip dislocation: is the physician to blame?].

Pediatrie·1993
Same journal

[Renal tubular acidosis in children].

Pediatrie·1993
Same journal

[CD23: structures, functions and practical perspectives in allergy reactions].

Pediatrie·1993
Same journal

[Accessory thymus in cervical ectopy: apropos of a case].

Pediatrie·1993
See all related articles

Area of Science:

  • Pediatric rheumatology
  • Autoimmune myopathies
  • Dermatology

Context:

  • Juvenile dermatomyositis (JDM) is an uncommon autoimmune disease affecting children.
  • It typically presents with insidious onset, symmetrical proximal muscle weakness, and characteristic skin rash.
  • Untreated JDM can lead to severe disability and mortality from respiratory complications.

Purpose:

  • To outline the diagnostic criteria for juvenile dermatomyositis.
  • To describe the primary pathology, which involves vasculitis affecting small vessels.
  • To discuss treatment strategies and prognoses for childhood dermatomyositis.

Summary:

  • Diagnosis requires 3-4 specific criteria plus a rash, including symmetrical limb girdle weakness, myositis on biopsy, elevated muscle enzymes, and electromyographic changes.

Related Experiment Videos

  • The key pathology is small-vessel vasculitis affecting muscles, skin, and the gastrointestinal tract.
  • Juvenile dermatomyositis is highly responsive to corticosteroid therapy, typically prednisone, with a favorable remission rate.

    • Impact:

    • Early diagnosis and treatment with corticosteroids lead to good remission rates and minimal complications in most children.
    • Immunosuppressive agents like azathioprine, methotrexate, or cyclophosphamide are reserved for refractory cases.
    • Emerging therapies, such as Cyclosporine A, aim to reduce steroid dependency and associated side effects.